Israel Englander’s BioTelemetry, Inc. BEAT Stock Holding History

Israel Englander’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,000	Closed	-$203K	–	4908
2019 Q3	$203K	Buy	+5,000	New	+$216K	﹤0.01%	3783

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.69B AUM 46.33% 1-Year Est. Return

Israel Englander's BEAT Position: Q1 2021 in Review

Israel Englander sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 135,339 shares — an estimated $9.76M sold.

Israel Englander first reported a position in BEAT in Q3 2013 and held it in 25 quarters. The position peaked at $10.1M in Q3 2017. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Israel Englander reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Israel Englander sold 135,339 BioTelemetry, Inc. shares in Q1 2021, an estimated $9.76M.
Israel Englander first reported a position in BioTelemetry, Inc. in Q3 2013 and held it in 25 quarters.
Israel Englander's BioTelemetry, Inc. position peaked at $10.1M in Q3 2017.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Millennium Management's 13F filing for Q1 2021, filed 17 May 2021.